Dr. Frances Valdes-Albini, MD
Claim this profileUniversity of Miami
Studies Breast Cancer
Studies Cancer
6 reported clinical trials
20 drugs studied
Area of expertise
1Breast Cancer
HER2 positive
ER positive
Stage IV
2Cancer
HER2 positive
ER positive
ER negative
Affiliated Hospitals
Clinical Trials Frances Valdes-Albini, MD is currently running
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Early Treatment Switch Strategies
for Advanced Breast Cancer
The majority of patients (pts) with breast cancer have hormone receptor positive (HR+) disease, and this holds true for pts with advanced breast cancer (ABC). Currently frontline therapy for pts with HR+ ABC is antihormonal therapy with an aromatase inhibitor or selective estrogen receptor degrader plus a CDK4/6i. The proposed trial is a randomized study to further evaluate the potential benefit of switching a frontline regimen at the time that a molecular signal, ctDNA, suggests progression prior to detection of clinical progression using standard methods. The purpose of this study is to determine whether switching treatment earlier in the disease process, based on molecular progression, will increase the amount of time that a patient's metastatic breast cancer is controlled compared to patients with metastatic breast cancer who receive treatment later based on diagnostic imaging results or other methods currently used in medical practice.
Recruiting1 award Phase 213 criteria
More about Frances Valdes-Albini, MD
Clinical Trial Related1 year of experience running clinical trials · Led 6 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Frances Valdes-Albini, MD has experience with
- Tucatinib
- AI+CDK4/6i
- PI3K Inhibitor + AI
- Chemotherapy
- SERD+CDK4/6i
- MTOR Inhibitor + AI
Breakdown of trials Frances Valdes-Albini, MD has run
Breast Cancer
Cancer
Recurrence
Solid Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Frances Valdes-Albini, MD specialize in?
Frances Valdes-Albini, MD focuses on Breast Cancer and Cancer. In particular, much of their work with Breast Cancer has involved HER2 positive patients, or patients who are ER positive.
Is Frances Valdes-Albini, MD currently recruiting for clinical trials?
Yes, Frances Valdes-Albini, MD is currently recruiting for 3 clinical trials in Miami Florida. If you're interested in participating, you should apply.
Are there any treatments that Frances Valdes-Albini, MD has studied deeply?
Yes, Frances Valdes-Albini, MD has studied treatments such as Tucatinib, AI+CDK4/6i, PI3K inhibitor + AI.
What is the best way to schedule an appointment with Frances Valdes-Albini, MD?
Apply for one of the trials that Frances Valdes-Albini, MD is conducting.
What is the office address of Frances Valdes-Albini, MD?
The office of Frances Valdes-Albini, MD is located at: University of Miami, Miami, Florida 33136 United States. This is the address for their practice at the University of Miami.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.